Friday, 13 Jul 2018

You are here

Best to Rehab at Home Following Joint Replacement

A New York Times article sheds light on recent evidence suggesting that those undergoing hip or knee replacement will do just as well with home therapy compared to inpatient rehabilitation following surgery.

The rate of joint replacements has nearly doubled from 2000 to 2010, when an estimated 693,400 total knee replacements were performed.

The issue of home rehab is particularly important to those who live alone. Nonetheless, recent research suggests that the majority recover equally well if they go home and get outpatient rehabilitation, as opposed to weeks of inpatient rehab. 

A new Australian study compared 81 knee replacement patients who received 10 days of inpatient rehabilitation, followed by an eight-week home-based program against 84 patients got only the home-based rehab program. Six months after their surgery, there was no difference in mobility, pain, function or quality of life between those who got inpatient rehab and groups that got outpatient rehab.

It turns out that for many of these orthopedic patients more than half of the cost of total joint replacements is incurred during the postoperative period, with inpatient rehab costs being considerabily higher than outpatient rehab costs.

Such a change could reduce the overall costs by more than $10,000 per patient.

Moreover, those with outpatient rehabs are far less likely to have adverse events, including infections, DVT, etc.

 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Best of 2017: New EULAR Guidelines on Behçet's

At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented. These were developed by a multidisciplinary expert committee that reviewed the evidence from the medical literature and developed final set of 9 recommendations:

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.

Trump Blasts Drug Makers on the Price of Drugs

Reuter's reports Friday that President Donald Trump blasted drugmakers and healthcare “middlemen” for making prescription drugs unaffordable for Americans. Nonetheless, many healthcare stocks rose as it became clear the administration had avoided taking aggressive and direct measures to cut drug prices.

Here are many New Sources on this developing story: